Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

3-deazauridine

A synthetic analogue of nucleoside uridine lacking a ring nitrogen in the 3-position. 3-deazauridine inhibits cytidine synthase, thereby reducing intracellular levels of cytidine and deoxycytidine and disrupting DNA and RNA synthesis. This agent may trigger apoptosis and enhance differentiation of neoplastic cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	deazauridine
Chemical structure:	2(1H)-pyridinone, 4-hydroxy-1-beta-D-ribofuranosyl 4-hydroxy-1-(beta-D-ribopentofuranosyl)-2-pyridone
IND number:	12540
NSC code:	126849

3-deazauridine

Search NCI's Drug Dictionary